Industry Practices ABHI |
variety of methods including, among others, trade shows, missions and events.
The
shape of healthcare to come
Technology is providing answers to healthcare challenges in both developed and emerging countries, says Peter Ellingworth of the ABHI
Can you explain the range of medical technologies that the ABHI aims to champion? ABHI members include some of the world’s largest medical technology companies as well as a broad array of SMEs. Medical technologies span a large cross section of products and services from single-use medical consumables to implantable devices, and increasingly digital health solutions. The medical technology sector has
a fantastic story to tell. It holds the key to addressing many of the challenges facing health systems around the world, making healthcare more affordable and easier to access, while significantly improving patient outcomes and making healthcare more productive and efficient. Developments in digital technology and the advent of big data provide huge opportunities to re-shape the way healthcare is delivered, improve outcomes and challenge existing models of care.
What are the most common aspects of British medical technology that are demanded from abroad? The healthcare needs of emerging and developed markets are diverse and present opportunities for all segments of the UK Medical Technology sector. We have great strengths in many traditional areas of medtech as well as leading the way in areas such as woundcare, imaging and diagnostics.
global-opportunity.co.uk
Is the UK’s medical technology already held in high regard around the world because of the reputation of the NHS, or do you have to work hard to get international markets to invest in British products? In the work that we do to support our members trade across the world, it is always pleasing to hear how well the UK is thought of. That is testimony to Britain’s industrial strengths and also the NHS’s standing. It is that combination of expertise and quality that holds the key to ensuring continued success. Part of ABHI’s role over the coming years will be to build on that unique heritage so that more UK medtech companies expand their activity overseas – exports are vital to the growth of our sector and are the lifeblood of many SMEs.
Can you explain more about your relationship with UKTI and how you work alongside them? UKTI plays an important role in supporting industry to export. The network of commercial staff around the world based in the embassies and consulates develop vital relationships and provide local engagement and intelligence, which our members need when entering and developing business in key markets. ABHI works closely with
UKTI to help develop strategy and provide opportunities for industry to meet with potential partners overseas through a
Where are the major markets abroad for UK medical technology? How are these identified? In identifying critical overseas markets, we are led by our members and their focus and priority. Within ABHI this leadership is provided by our International Policy Group and several supporting geographic working groups constituted by our members. Through the work of our member networks, we establish strategy, tackle market access issues, shape and influence trade policy and assess overseas opportunities. These groups also conduct several industry surveys throughout the year and through these methods we prioritise key markets and focus our
activity.Beyond Western Europe, (which remains the UK’s main trading partner,) the USA, Middle East and Asia remain key markets. Throughout the course of the next year we will be extending the support and increasing our activities in these key geographies.
What are some of the nations and emerging markets that you hope to target in the future? We are active in many emerging markets. In the next twelve to eighteen months we will be focussing heavily on Asia. China particularly presents a significant opportunity. Its rate of growth and scale are staggering but it is a challenging market and we will need to ensure we are comprehensively supporting our members if we are to make the most of the potential it has to offer. The Middle East is another key region for UK companies. Our work in the region has included us taking the largest UK healthcare delegation to the Arab Health exhibition. Over 150 companies attended the show in Dubai at the end of January 2015. With help from our partners and members ABHI was able to showcase the best of the industry in a simulated operating theatre environment in the ABHI UK Pavilion. UK Providers, clinicians and technology companies simulated surgical procedures throughout the show to visitors from across the Gulf. The trade show was a huge success and we will be looking to build on this for the future.
Further information
www.abhi.org.uk
Issue 01 | Global Opportunity Healthcare 2015 191
ABHI
|
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188 |
Page 189 |
Page 190 |
Page 191 |
Page 192 |
Page 193 |
Page 194 |
Page 195 |
Page 196 |
Page 197 |
Page 198 |
Page 199 |
Page 200 |
Page 201 |
Page 202 |
Page 203 |
Page 204